BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16214174)

  • 1. Exploiting genotypic differences to identify genes important for EAE development.
    Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S
    J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
    Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
    J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.
    Chabas D; Baranzini SE; Mitchell D; Bernard CC; Rittling SR; Denhardt DT; Sobel RA; Lock C; Karpuj M; Pedotti R; Heller R; Oksenberg JR; Steinman L
    Science; 2001 Nov; 294(5547):1731-5. PubMed ID: 11721059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process.
    Mix E; Ibrahim S; Pahnke J; Koczan D; Sina C; Böttcher T; Thiesen HJ; Rolfs A
    J Neuroimmunol; 2004 Jun; 151(1-2):158-70. PubMed ID: 15145614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells.
    Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y
    J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin.
    Paintlia AS; Paintlia MK; Singh AK; Stanislaus R; Gilg AG; Barbosa E; Singh I
    J Neurosci Res; 2004 Jul; 77(1):63-81. PubMed ID: 15197739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
    Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
    Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes stimulate interleukin-17 and interferon-gamma production in vitro.
    Miljkovic D; Momcilovic M; Stojanovic I; Stosic-Grujicic S; Ramic Z; Mostarica-Stojkovic M
    J Neurosci Res; 2007 Dec; 85(16):3598-606. PubMed ID: 17969033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide.
    Willenborg DO; Fordham SA; Staykova MA; Ramshaw IA; Cowden WB
    J Immunol; 1999 Nov; 163(10):5278-86. PubMed ID: 10553050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
    Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
    J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
    Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T
    Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma confers resistance to experimental allergic encephalomyelitis.
    Krakowski M; Owens T
    Eur J Immunol; 1996 Jul; 26(7):1641-6. PubMed ID: 8766573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis.
    Rajan AJ; Klein JD; Brosnan CF
    J Immunol; 1998 Jun; 160(12):5955-62. PubMed ID: 9637509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity.
    Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ
    J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
    Ferber IA; Brocke S; Taylor-Edwards C; Ridgway W; Dinisco C; Steinman L; Dalton D; Fathman CG
    J Immunol; 1996 Jan; 156(1):5-7. PubMed ID: 8598493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.
    Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT
    J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.
    Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A
    Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.